Recent advancements in genetics research have shed light on new genes that may be linked to common psychiatric disorders such as schizophrenia and bipolar disorder. These disorders affect millions of people globally and are known to have a strong genetic component. While no single gene determines the risk of developing these disorders, a combination of genes is believed to play a role. Researchers at Stanford University have utilized artificial intelligence to identify complex genetic variants scattered throughout the human genome that could potentially contribute to these psychiatric conditions. A recent study suggests that mutations occurring after fertilization, including genetic mosaicism, may be implicated in disorders like bipolar disorder and schizophrenia.
Our genome can be compared to a dynamic book containing instructions for every cell in our body, with genes serving as the chapters. These genes, numbering around 20,000, provide instructions for the production of proteins essential for life. While most genes are non-coding and do not directly instruct protein synthesis, they play crucial roles in genetic regulation and cellular function.
Genetic variants, whether in coding or non-coding regions, can disrupt the accurate translation of genetic instructions within cells. Small spelling errors may have minimal impact, but larger changes can lead to the omission of crucial information, potentially contributing to various disorders affecting different aspects of the body.
Our genes are a combination of DNA inherited from our parents, with two copies of each gene—one from each parent—determining traits and health risks. The process of DNA replication during cell division is prone to errors, leading to genetic changes not present in the parental DNA. This phenomenon, known as genetic mosaicism, results in distinct cell populations with different genetic compositions within the body. Genetic mosaicism can manifest as unique traits like heterochromia (two differently colored eyes) or mosaic skin patterns. Conditions such as developmental delays, autism, epilepsy, and certain cancers have been associated with mosaicism, highlighting its role in various health outcomes.
Genetic variants can also be acquired throughout an individual’s lifespan due to factors like exposure to environmental toxins, infections, or random errors in DNA replication. Lifestyle choices, aging, and inflammation can further exacerbate DNA damage, adding to the complexity of genetic variation and its potential impact on health.
Whole genome sequencing (WGS) is a powerful tool that can identify subtle DNA changes by mapping an individual’s entire genome and comparing it to a reference genome. This technology enables the detection of genetic variants associated with disorders, aiding in personalized medicine and disease management.
Researchers, led by Alexander Urban at Stanford, emphasize the importance of identifying complex genetic variations that may contribute to psychiatric disorders. Through their study, they discovered over 8,000 complex variants in individuals with bipolar disorder and schizophrenia, many of which were located in regions of the genome linked to brain function. By utilizing AI algorithms trained to recognize diverse genetic patterns, researchers were able to pinpoint specific genetic changes associated with these disorders.
The study’s findings provide valuable insights into the genetic basis of psychiatric disorders and pave the way for personalized treatment approaches. As genetic research continues to evolve, future studies may uncover more intricate relationships between genetic variants and various health conditions, enhancing our understanding of the human genome and its implications for personalized healthcare strategies.
